For the Inventor, By the Inventor

Enter assignee name

Toronto, Canada

Interface Biologics, Inc.

USPTO Granted Patents = 21

CIPO Patents = 3

EPO Patents = 7

Trademarks = 3

Forward Citations = 187

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Paul Joseph Santerre (12 out of 38 patents)

Roseita Esfand (10 out of 12 patents)

Sanjoy Mullick (8 out of 15 patents)

4. Weilun Chang (7 out of 11 patents)

5. Hanje Chen (5 out of 6 patents)

6. Jeannette Ho (4 out of 13 patents)

7. Mark A Steedman (4 out of 5 patents)

8. Richard Witmeyer (4 out of 5 patents)

9. Raymond Lareau (3 out of 35 patents)

10. Benjamin Bell (3 out of 18 patents)

11. Bernadette Ilagan (3 out of 3 patents)

12. Meilin Yang (3 out of 3 patents)

13. Alexandra Piotrowicz (3 out of 4 patents)

14. Frank Laronde (3 out of 3 patents)

15. Sylvia Tjahyadi (2 out of 2 patents)

21 patents: Sort by Forward Citations

1. 11766511 - Antithrombogenic hollow fiber membranes and filters (2023-09-26),

2. 11318232 - Compositions and methods for delivering drugs to a vessel wall (2022-05-03),

3. 10195311 - Local delivery of drugs from self assembled coatings (2019-02-05),

4. 10039864 - Oligofluorinated cross-linked polymers and uses thereof (2018-08-07),

5. 9884146 - Antithrombogenic hollow fiber membranes and filters (2018-02-06),

6. 9764884 - Packaging materials including a barrier film (2017-09-19),

7. 9744269 - Thermoplastic polyurethane admixtures (2017-08-29),

8. 9206283 - Thermoplastic polyurethane admixtures (2015-12-08),

9. 8962697 - Bioreponsive polymers (2015-02-24),

10. 8900603 - Local delivery of drugs from self assembled coatings (2014-12-02),

11. 8877062 - Antithrombogenic hollow fiber membranes and filters (2014-11-04),

12. 8784402 - Catheters with fluoropolymer additives (2014-07-22),

13. 8574604 - Methods and compositions for the delivery of biologically active agents (2013-11-05),

14. 8445016 - Grafted polymers and uses thereof (2013-05-21),

15. 8440176 - Covalently grafted pharmaceutically active polymers (2013-05-14),

Interface Biologics is a company that specializes in creating and commercializing innovative materials for the medical device and drug delivery industries. Their proprietary technologies are designed to improve the safety and effectiveness of medical products and enhance patient outcomes. With a focus on surface modification and drug delivery technologies, Interface Biologics aims to partner with companies to develop and enhance their products. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#67 in Toronto

#648 in Canada

#29,080 in the World

Toronto, Canada

Interface Biologics, Inc.

Forward Citations = 187

25 inventors:

Paul Joseph Santerre (12 out of 38 patents)

Roseita Esfand (10 out of 12 patents)

Sanjoy Mullick (8 out of 15 patents)

4. Weilun Chang (7 out of 11 patents)

5. Hanje Chen (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…